Note: Ingredients listed on restricted chemical lists
EC/CAS
14807-96-6
Name of the chemical
Talc
Concentration
N/A
EC/CAS
238-877-9
Name of the chemical
Talc: Hydrated magnesium silicate
Concentration
N/A
EC/CAS
209-150-3
Name of the chemical
Aluminium, zinc, magnesium and calcium stearates
Concentration
N/A
General Information
Revision date
2010-04-07
Product name
Lincocin
Emergency telephone
(24 hours) 1-800-424-9300
Icons in SDS
Company Information
company name
Pfizer Inc
e-mail address of the competent person responsible for the Safety Data Sheet
pfizer-MSDS@pfizer.com
GHS Information
Signal word
WARNING
Section 2
SECTION 2: Hazards identification
Appearance: Blue capsules ; white powder
Signal word
WARNING
Hazard statements
May cause allergic skin reaction.
Additional information
Short Term: Individuals sensitive to this chemical or other materials in its chemical class may develop allergic reactions. Known Clinical Effects: The most common adverse effects reported with clinical use were diarrhea, nausea, rash, and vomiting. Effects on blood and blood-forming organs have also occurred. This compound can cross the placenta in pregnant women. Secreted in human breast milk.
EU Classification
EU Indication of danger: Irritant EU Hazard Symbols: EU Risk Phrases: R43 - May cause sensitization by skin contact. Australian Hazard Classification
Hazardous Ingredients
Non-Dangerous Goods (NOHSC): Note: This document has been prepared in accordance with standards for workplace safety, which require the inclusion of all known hazards of the active substance or its intermediates regardless of the potential risk. The precautionary statements and warnings included may not apply in all cases. Your needs may vary depending upon the potential for exposure in your workplace.
